BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 11124826)

  • 1. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat.
    Peralta C; Fernández L; Panés J; Prats N; Sans M; Piqué JM; Gelpí E; Roselló-Catafau J
    Hepatology; 2001 Jan; 33(1):100-13. PubMed ID: 11124826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat.
    Peralta C; Prats N; Xaus C; Gelpí E; Roselló-Catafau J
    Hepatology; 1999 Dec; 30(6):1481-9. PubMed ID: 10573528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.
    Teoh N; Leclercq I; Pena AD; Farrell G
    Hepatology; 2003 Jan; 37(1):118-28. PubMed ID: 12500196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion.
    Köksoy C; Kuzu MA; Kuzu I; Ergün H; Gürhan I
    Br J Surg; 2001 Mar; 88(3):464-8. PubMed ID: 11260117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of glutathione against liver warm ischemia-reperfusion injury in rats is associated with regulation of P-selectin and neutrophil infiltration.
    Xue F; Wang G; Pang Z; Liu C; Liang T
    Anat Rec (Hoboken); 2008 Aug; 291(8):1016-22. PubMed ID: 18521901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat.
    Peralta C; Bartrons R; Serafin A; Blázquez C; Guzmán M; Prats N; Xaus C; Cutillas B; Gelpí E; Roselló-Catafau J
    Hepatology; 2001 Dec; 34(6):1164-73. PubMed ID: 11732006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Pawlik WW
    Eur J Pharmacol; 2004 Sep; 499(1-2):201-13. PubMed ID: 15363968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat.
    Colletti LM; Kunkel SL; Walz A; Burdick MD; Kunkel RG; Wilke CA; Strieter RM
    Hepatology; 1996 Mar; 23(3):506-14. PubMed ID: 8617430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
    Harada N; Okajima K; Murakami K; Usune S; Sato C; Ohshima K; Katsuragi T
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1034-42. PubMed ID: 10945856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against lung damage in reduced-size liver transplantation.
    Franco-Gou R; Roselló-Catafau J; Peralta C
    Crit Care Med; 2006 May; 34(5):1506-13. PubMed ID: 16540955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edaravone reduces ischemia-reperfusion injury mediators in rat liver.
    Taniguchi M; Uchinami M; Doi K; Yoshida M; Sasaki H; Tamagawa K; Horiuchi T; Tanaka K
    J Surg Res; 2007 Jan; 137(1):69-74. PubMed ID: 17064733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning protects liver and lung damage in rat liver transplantation: role of xanthine/xanthine oxidase.
    Fernández L; Heredia N; Grande L; Gómez G; Rimola A; Marco A; Gelpí E; Roselló-Catafau J; Peralta C
    Hepatology; 2002 Sep; 36(3):562-72. PubMed ID: 12198648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion.
    Peralta C; Perales JC; Bartrons R; Mitchell C; Gilgenkrantz H; Xaus C; Prats N; Fernández L; Gelpí E; Panés J; Roselló-Catafau J
    Am J Pathol; 2002 Jun; 160(6):2111-22. PubMed ID: 12057915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desferal attenuates TNF release following hepatic ischemia/reperfusion.
    Colletti LM; Remick DG; Campbell DA
    J Surg Res; 1994 Oct; 57(4):447-53. PubMed ID: 7934022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent.
    Camargo CA; Madden JF; Gao W; Selvan RS; Clavien PA
    Hepatology; 1997 Dec; 26(6):1513-20. PubMed ID: 9397992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of remote hepatic injury in the rat: interactions between Kupffer cells, tumor necrosis factor-alpha, and microvascular perfusion.
    Brock RW; Lawlor DK; Harris KA; Potter RF
    Hepatology; 1999 Jul; 30(1):137-42. PubMed ID: 10385649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertonic preconditioning prevents hepatocellular injury following ischemia/reperfusion in mice: a role for interleukin 10.
    Oreopoulos GD; Wu H; Szaszi K; Fan J; Marshall JC; Khadaroo RG; He R; Kapus A; Rotstein OD
    Hepatology; 2004 Jul; 40(1):211-20. PubMed ID: 15239105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia.
    Waldow T; Alexiou K; Witt W; Albrecht S; Wagner F; Knaut M; Matschke K
    Transpl Int; 2005 Feb; 18(2):198-205. PubMed ID: 15691273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion.
    Serafín A; Roselló-Catafau J; Prats N; Gelpí E; Rodés J; Peralta C
    Hepatology; 2004 Mar; 39(3):688-98. PubMed ID: 14999687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha.
    Esposito E; Mazzon E; Muià C; Meli R; Sessa E; Cuzzocrea S
    J Leukoc Biol; 2007 Apr; 81(4):1032-43. PubMed ID: 17210619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.